Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma
Clinical trial NCT05460767 · UNKNOWN
Trial details
- NCT number
- NCT05460767
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2024-03-31
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.